FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-002773-39-SE
Enrollment
Unknown
Registered
2011-08-30
Start date
2011-09-28
Completion date
Unknown
Last updated
2012-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Spironolakton Nycomed Pharmaceutical Form: Tablet INN or Proposed INN: Spironolakton Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50-

Sponsors

Universitetssjukhuset Örebro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Sweden

Contacts

Public ContactOlof Hellberg

Universitetssjukhuset Örebro

+4619602 10 00

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026